FrancophonIA/ELRC3.0 huggingface dataset:
English: Ribavirin Mylan dose based on body weight when used in combination with interferon alfa-2b or peginterferon alfa-2b in children above 3 years of age and adolescents
Danish: Ribavirin Mylan-dosis baseret på kropsvægt ved anvendelse i kombination med interferon alfa-2b eller peginterferon alfa-2b hos børn over 3 år samt unge
English: Patients co-infected with HCV/HIV: Patients taking NRTI treatment in association with ribavirin and interferon alfa-2b may be at increased risk of mitochondrial toxicity, lactic acidosis and hepatic decompensation (see section 4.4).
Danish: Patienter, der er co-inficerede med HCV/HIV: Patienter, der får NRTI-behandling i forbindelse med ribavirin og interferon alfa-2b kan have større risiko for mitokondrietoksicitet, laktatacidose og hepatisk dekompensation (se pkt.
English: Lack of early virologic response by treatment week 12 (detectable HCV-RNA with a < 2 log10 reduction from baseline) was a criterion for discontinuation of treatment.
Danish: * (HCV-RNA PCR analyse, med en nedre kvantificeringsgrænse på 27 IE/ml) Mangel på tidligt virologisk respons ved behandlingsuge 12 (detekterbar HCV-RNA med < 2 log10 reduktion fra baseline) var et kriterium for seponering af behandlingen.
English: Reminder: Please read the “Other medicines” section of the Package Leaflet for interferon alfa-2b before you begin combination treatment with this medicine.
Danish: Husk: Læs afsnittet "Andre lægemidler" i indlægssedlen for interferon alfa-2b, før du påbegynder en kombinationsbehandling med dette lægemiddel.
English: Reported adverse reactions listed in Table 6 are based on experience from the two multicentre children and adolescents clinical trials using ribavirin with interferon alfa-2b or peginterferon alfa-2b.
Danish: Rapporterede bivirkninger i Tabel 6 er baseret på erfaring fra de to multicenter kliniske undersøgelser med børn og unge i behandling med ribavirin med interferon alfa-2b eller peginterferon alfa-2b.
English: Unit Dose Blisters:
Danish: Enkeltdosis-blisterpakning:
English: 2 capsules in the morning and 2 capsules in the evening See adult dose
Danish: 2 kapsler om morgenen og 2 kapsler om aftenen
English: • Ribavirin (1,000/1,200 mg/day) + peginterferon alfa-2b (1.5 micrograms/kg/week for one month followed by 0.5 microgram/kg/week for 11 months) (n=514).
Danish: • ribavirin (1.000/1.200 mg/dag) + peginterferon alfa-2b (1,5 mikrogram/kg/uge i en måned efterfulgt af 0,5 mikrogram/kg/uge i 11 måneder) (n = 514).
English: Please refer to the corresponding SmPC of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with ribavirin in combination with peginterferon alfa-2b.
Danish: Se de tilsvarende produktresumeer for de antiretrovirale lægemidler, der skal tages sideløbende med HCV-behandling, for bevidsthed om og håndtering af toksiciteter specifikt for hvert produkt samt potentialet for overlappende toksiciteter med ribavirin i kombination med peginterferon alfa-2b.
English: Uncommonly reported side effects (may affect up to 1 in 100 people): hearing or seeing images that are not present, heart attack, panic attack, hypersensitivity reaction to the medication,
Danish: Ualmindelige bivirkninger (forekommer hos op til 1 ud af 100 patienter): - at høre eller se billeder, der ikke er til stede, - hjerteanfald, panikanfald, - overfølsomhedsreaktion over for medicinen, - betændelse i bugspytkirtlen, knoglesmerte, diabetes mellitus (sukkersyge), - muskelsvaghed.
English: Patients were randomized to receive either ribavirin (800-1,200 mg/day based on weight) plus peginterferon alfa-2b (100 or 150 µg/week based on weight) or ribavirin (800-1,200 mg/day based on weight) plus interferon alfa-2b (3 MIU TIW).
Danish: Patienterne blev randomiseret til enten at modtage ribavirin (800-1.200 mg/dag baseret på vægt) plus peginterferon alfa-2b (100 eller 150 μg/uge baseret på vægt) eller ribavirin (800-1.200 mg/dag baseret på vægt) plus interferon alfa-2b (3 MIE TIW).
English: For HCV/HIV co-infected patients receiving ribavirin in combination with peginterferon alfa-2b, other adverse reactions (that were not reported in mono-infected patients) which have been reported in the studies with a frequency > 5% were: oral candidiasis (14%), lipodystrophy acquired (13%), CD4 lymphocytes decreased (8%), appetite decreased (8%), gamma-glutamyltransferase increased (9%), back pain (5%), blood amylase increased (6%), blood lactic acid increased (5%), cytolytic hepatitis (6%), lipase increased (6%) and pain in limb (6%).
Danish: Bivirkningerne, der har været rapporteret i undersøgelserne med en hyppighed > 5 % var: oral candidiasis (14 %), pådraget lipodystrofi (13 %), nedsat CD4-lymfocytter (8 %), nedsat appetit (8 %), øget gammaglutamyltransferase (9 %), rygsmerter (5 %), øget amylase i blodet (6 %), øget mælkesyre i blodet (5 %), cytolytisk hepatitis (6 %), øget lipase (6 %) og smerte i lemmerne (6 %).
English: Table 5 Adverse reactions reported during clinical trials or following the marketing use of ribavirin with pegylated interferon alfa-2b or interferon alfa-2b System Organ Class
Danish: Tabel 5 Bivirkninger set i kliniske undersøgelser og efter markedsføring af ribavirin med pegyleret interferon alfa-2b eller interferon alfa-2b Systemorganklasse
English: Reminder: Please read the “Do not take” section of the Package Leaflet for interferon alfa-2b before you begin used in combination with this medicine.
Danish: Bemærk: Læs afsnittet ”Tag ikke” i indlægssedlen for interferon alfa-2b, før du begynder kombineret brug sammen med dette lægemiddel.
English: Suicidal ideation, psychosis, aggressive behaviour, confusion, agitation, anger, mood altered, abnormal behaviour, nervousness, sleep disorder, decreased libido, apathy, abnormal dreams, crying
Danish: Selvmordstanker, psykose, aggressiv opførsel, forvirring, agitation, vrede, humørændring, unormal adfærd, nervøsitet, søvnforstyrrelser, nedsat libido, apati, abnorme drømme, gråd
English: Ribavirin (800 mg/day) + interferon alfa2b (3 MIU TIW)
Danish: ribavirin (800 mg) + interferon alfa-2b (3 MIE TIW)
English: Please refer to the corresponding SmPC of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with ribavirin and peginterferon alfa-2b.
Danish: Se de tilsvarende produktresumeer for de antiretrovirale lægemidler, der skal tages sideløbende med HCV-behandling, for bevidsthed om og håndtering af toksiciteter specifikt for hvert produkt samt potentialet for overlappende toksiciteter med ribavirin og peginterferon alfa-2b.
English: Please refer also to the interferon alfa-2b Summary of Product Characteristics (SmPC) for prescribing information particular to that product.
Danish: Se også produktresuméet for interferon alfa-2b for ordinationsinformation for det pågældende produkt.
English: Safety and effectiveness of Ribavirin Mylan with pegylated or other forms of interferon (i.e. not alfa-2b) in these patients have not been evaluated.
Danish: Sikkerhed og effektivitet ved brug af Ribavirin Mylan sammen med pegyleret interferon eller andre former for interferon (dvs. ikke alfa-2b) er ikke blevet evalueret, hvad angår denne patientgruppe.
English: - The use of Ribavirin and interferon alfa-2b or peginterferon alfa-2b in children and adolescents with existence of or history of severe psychiatric conditions is contraindicated (see section 4.3).
Danish: Brug af ribavirin og interferon alfa-2b eller peginterferon alfa-2b hos børn og unge med aktuelleeller tidligere alvorlige psykiatriske lidelser er kontraindiceret (se pkt.
English: End of treatment response
Danish: Respons ved afslutning af behandlingen Tilbagefald
English: Information on excipients
Danish: Oplysninger om hjælpestoffer
English: In a non-comparative trial, 2,293 patients with moderate to severe fibrosis who failed previous treatment with combination alpha interferon/ribavirin were retreated with peginterferon alfa-2b, 1.5 microgram/kg subcutaneously, once weekly, in combination with weight adjusted ribavirin.
Danish: 2.293 patienter i en ikke sammenligningsundersøgelse, som havde moderat til svær fibrose, hvor tidligere behandling med kombinationen af alfa interferon/ribavirin var uden effekt, blev behandlet med peginterferon alfa-2b givet subkutant (1,5 mikrogram/kg/uge) i kombination med ribavirin baseret på legemsvægt.
English: > 5 mg/dL
Danish: > 5 mg/dl > 4 mg/dl
English: The recommended dose of Ribavirin Mylan combined with interferon alfa-2b or peginterferon alfa-2b, is shown in the below table.
Danish: Den anbefalede dosis for Ribavirin Mylan kombineret med interferon alfa-2b eller peginterferon alfa-2b er angivet i tabellen nedenfor.
English: P1.5/R Ribavirin (800 mg) + peginterferon alfa-2b (1.5 micrograms/kg) P0.5/R Ribavirin (1,000/1,200 mg) + peginterferon alfa-2b (1.5 to 0.5 microgram/kg) I/R Ribavirin (1,000/1,200 mg) + interferon alfa-2b (3 MIU)
Danish: P1,5/R ribavirin (800 mg) + peginterferon alfa-2b (1,5 mikrogram/kg) P0,5/R ribavirin (1.000/1.200 mg) + peginterferon alfa-2b (1,5 til 0,5 mikrogram/kg) I/R
English: • Ribavirin (800 mg/day) + peginterferon alfa-2b (1.5 micrograms/kg/week) (n=511).
Danish: • ribavirin (800 mg/dag) + peginterferon alfa-2b (1,5 mikrogram/kg/uge) (n = 511).
English: Haemoglobin levels dropped below 10 g/dl in up to 14% of adult patients and 7% of children and adolescents treated with ribavirin in combination with either peginterferon alfa-2b or interferon alfa2b.
Danish: Hæmoglobinværdierne faldt til under 10 g/dl hos op til 14 % voksne patienter og 7 % børn og unge behandlet med ribavirin i kombination med enten peginterferon alfa-2b eller interferon alfa-2b.
English: For example, the body weight dosing used in conjunction with interferon alfa-2b or peginterferon alfa-2b is shown in Table 1.
Danish: For eksempel vises kropsvægtsdoseringen, som anvendes sammen med interferon alfa-2b eller peginterferon alfa-2b, i Tabel 1.
English: Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin for discontinuation or dose modification recommendations.
Danish: Se det tilsvarende produktresume for lægemidler, der anvendes i kombination med ribavirin, for anbefalinger til seponering eller dosisændring.
English: Ribavirin Mylan must be used in combination with interferon alfa-2b.
Danish: Ribavirin Mylan skal bruges i kombination med interferon alfa-2b.
English: Also, refer to peginterferon alfa2b and interferon alfa-2b SmPCs for adverse reactions that may be attributable to interferons monotherapy.
Danish: Desuden refererer produktresumeerne for peginterferon alfa-2b og interferon alfa-2b til bivirkninger, der kan tilskrives interferoners monoterapi.
English: There is no safety or efficacy information on the use of Ribavirin Mylan with pegylated or other forms of interferon (i.e., not alfa-2b).
Danish: Der foreligger ikke oplysninger om sikkerhed og virkning ved brug af Ribavirin Mylan sammen med pegylerede eller andre former af interferon (dvs.: ikke alfa-2b).
English: Ribavirin Mylan must not be used without interferon alfa-2b, i.e.
Danish: Ribavirin Mylan må ikke bruges uden interferon alfa-2b.
English: Please refer to the corresponding Summary of Product Characteristics (SmPC) of medicinal products used in combination with ribavirin for additional prescribing information particular to that product and for further dosage recommendations on co-administration with ribavirin.
Danish: Se det tilsvarende produktresume (SmPC) for lægemidler, der anvendes i kombination med ribavirin for yderligere ordinationsoplysninger specifikt for produktet og for yderligere doseringsanbefalinger ved samtidig administration med ribavirin.
English: Stevens Johnson syndrome*, toxic epidermal necrolysis*, erythema multiforme* Musculoskeletal and connective tissue disorders Very common:
Danish: Stevens Johnson syndrom٭, toksisk epidermal nekrolyse٭, erytema multiforme ٭
English: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, Section 4.2)
Danish: Lægemidlet må kun udleveres efter ordination på en recept udstedt af en begrænset lægegruppe (se bilag I: Produktresumé; pkt.
English: Abnormal behaviour, depressed mood, emotional disorder, fear, nightmare Nervous system disorders
Danish: Abnorm opførelse, nedtrykt humør, følelsesmæssig forstyrrelse, frygt, mareridt
English: A decrease in haemoglobin levels to < 10 g/dl was observed in up to 14% of adult patients and 7% of children and adolescents treated with ribavirin in combination with peginterferon alfa-2b or interferon alfa-2b in clinical trials.
Danish: Et fald i hæmoglobin niveau til < 10 g/dl blev set hos op til 14 % af voksne patienter og hos 7 % af børn og unge behandlet med ribavirin i kombination med peginterferon alfa-2b eller interferon alfa-2b i kliniske undersøgelser.
English: • Dental and periodontal disorders: Dental and gum disorders have been reported in patients receiving ribavirin in combination with (peg)interferon alfa-2b.
Danish: Dentale og parodontale lidelser: Der er registreret tand- og tandkødslidelser hos patienter, som fik ribavirin i kombination med (peg)interferon alfa-2b.
English: Table 1 Ribavirin Mylan dose based on body weight when used in combination with interferon alfa-2b or peginterferon alfa-2b in paediatric patients Patient weight (kg)
Danish: Tabel 1 Ribavirin Mylan-dosis baseret på kropsvægt ved anvendelse i kombination med interferon alfa-2b eller peginterferon alfa-2b hos pædiatriske patienter
English: Fungal infection, bacterial infection, pulmonary infection, nasopharyngitis, pharyngitis streptococcal, otitis media, sinusitis, tooth abscess, influenza, oral herpes, herpes simplex, urinary tract infection, vaginitis, gastroenteritis
Danish: Svampeinfektion, bakterieinfektion, pulmonær infektion, nasopharyngitis, streptokok betændelse i svælget, otitis media, sinuitis, tandbylder, influenza, oral herpes, herpes simplex, urinvejsinfektion, vaginitis, gastroenteritis
English: Each capsule contains 200 mg ribavirin.
Danish: Hver kapsel indeholder 200 mg ribavirin.
English: This Leaflet was Last Approved In.
Danish: Denne indlægsseddel blev senest ændret
English: This medicine in combination with peginterferon alfa-2b or interferon alfa-2b may also cause: dark, cloudy or abnormally coloured urine, difficulty breathing, changes in the way your heart beats, chest pain, pain down left arm, jaw pain, loss of consciousness, loss of use, drooping or loss of power of facial muscles, loss of feeling sensation, loss of vision.
Danish: Dette lægemiddel i kombination med peginterferon alfa-2b eller interferon alfa-2b kan også forårsage: - mørk, grumset eller unormalt farvet urin, - vejrtrækningsproblemer, ændringer i den måde dit hjerte slår, brystsmerte, smerte i venstre arm,
English: p value b
Danish: pværdi b
English: Table 6 Adverse reactions very commonly, commonly and uncommonly reported during clinical trials in children and adolescents with ribavirin in combination with interferon alfa-2b or peginterferon alfa-2b System Organ Class
Danish: Tabel 6 Meget almindelige, almindelige og ikke almindelige bivirkninger rapporteret i kliniske undersøgelser af ribavirin i kombination med interferon alfa-2b eller peginterferon alfa2b i børn og unge Systemorganklasse
English: Each hard capsule contains 200 mg ribavirin.
Danish: Hver hårde kapsel indeholder 200 mg ribavirin.
English: Previously treated patients - Retreatment of prior treatment failures (relapse and non-responder patients) with peginterferon alfa2b in combination with ribavirin:
Danish: Tidligere behandlede patienter - Genbehandling af patienter hvor behandling med peginterferon alfa 2b i kombination med ribavirin tidligere har været uden effekt (relaps og non responder patienter):
English: Rarely reported side effects (may affect up to 1 in 1,000 people): seizure (convulsions), pneumonia, rheumatoid arthritis, kidney problems, dark or bloody stools, intense abdominal pain, sarcoidosis (a disease characterised by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands), vasculitis.
Danish: Sjældne bivirkninger (forekommer hos op til 1 ud af 1.000 patienter): - anfald (kramper), - lungebetændelse, - reumatoid arthrit, nyreproblemer, - mørk eller blodig afføring, intense mavesmerter, - sarkoidose (en sygdom karakteriseret ved længerevarende feber, vægttab, ledsmerte og
English: Ribavirin in combination with interferon alfa-2b:
Danish: Ribavirin i kombination med interferon alfa-2b:
English: In a clinical trial with 107 children and adolescent patients (3 to 17 years of age) treated with combination therapy of peginterferon alfa-2b and ribavirin, dose modifications were required in 25 %
Danish: I et klinisk forsøg med 107 børn og unge patienter (3 til 17 år) behandlet med peginterferon alfa-2b og ribavirin som kombinationbehandling var dosis ændring nødvendig hos 25 % af patienterne, mest almindeligt for anæmi, neutropeni og vægttab.
English: Please refer to the SmPC of the corresponding DAA for a full description of the clinical data with such combination.
Danish: Ribavirin i kombination med direkte antiviralt lægemiddel (DAA, Direct Antiviral Agent): Se produktresumeet for det tilsvarende DAA for en udførlig beskrivelse af de kliniske data med en sådan kombination.
English: Please refer to the corresponding SmPC of medicinal products that are used in combination with ribavirin for additional undesirable effects reported with these products.
Danish: Se de tilsvarende produktresumeer for lægemidler, der anvendes i kombination med ribavirin, for yderligere indberettede bivirkninger for disse produkter.
English: Pancreatitis, oral pain
Danish: Pancreatitis, mundsmerter
English: The decision to treat should be made on a case by case basis (see section 4.4).
Danish: Beslutningen bør tages på grundlag af en vurdering af den enkelte patient (se pkt.
English: By Week 12*** (n= 915)
Danish: 3 gange om ugen (n = 54)
English: Psoriasis, aggravated psoriasis, eczema, photosensitivity reaction, maculopapular rash, erythematous rash, night sweats, hyperhidrosis, dermatitis, acne, furuncule, erythema, urticaria, skin disorder, bruise, sweating increased, abnormal hair texture, nail disorder*
Danish: Psoriasis, forværret psoriasis, eksem, lysoverfølsomhedsreaktion, maculopapuløst udslæt, erythematøst udslæt, nattesved, hyperhidrosis, dermatitis, akne, furunkulose٭, erythem, urticaria, hudlidelse, blå mærker, øget svedtendens, unormal hårstruktur, neglelidelse٭
English: The study results are summarized in Table 13.
Danish: Undersøgelsens resultater er sammenfattet i
English: Blisters - No special storage conditions.
Danish: Blisterpakning: Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen.
English: Adult patients: Ribavirin Mylan is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with chronic hepatitis C who have previously responded (with normalisation of ALT at the end of treatment) to interferon alpha monotherapy but who have subsequently relapsed (see section 5.1).
Danish: Patienter, der tidligere har været behandlet uden terapeutisk effekt Voksne patienter: Ribavirin Mylan er, i kombination med interferon alfa-2b, indiceret til behandling af vokse patienter med kronisk hepatitis C, som tidligere har responderet (med normalisering af ALAT ved afslutningen af behandlingen) på interferon alfa-monoterapi, men som siden har oplevet tilbagefald (se pkt.
English: Genotype 1 ≤ 600,000 IU/ml
Danish: Genotype 1  600.000 IE/ml
English: Conditions or restrictions regarding supply and use imposed on the marketing authorisation holder
Danish: • Betingelser eller begrænsninger pålagt indehaveren af markedsføringstilladelsen vedrørende udlevering og brug
English: No data are available regarding dose modification for paediatric patients with renal impairment (see sections 4.2 and 5.2).
Danish: Der foreligger ingen data om dosisændring for pædiatriske patienter med nedsat nyrefunktion (se pkt.
English: Prior Response Relapse
Danish: Tidligere respons Tilbagefald
English: Pharmacotherapeutic group: antivirals for systemic use, nucleosides and nucleotides excl. reverse transcriptase inhibitors, ATC code: J05AB04.
Danish: Farmakoterapeutisk gruppe: antivirale lægemidler til systemisk brug, nukleosider og nukleotider ekskl.
English: What Ribavirin Mylan is and what it is used for What you need to know before you take Ribavirin Mylan How to take Ribavirin Mylan Possible side effects
Danish: Det skal du vide, før du begynder at tage Ribavirin Mylan Sådan skal du tage Ribavirin Mylan Bivirkninger
English: Patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Danish: Hver Ribavirin Mylan hård kapsel indeholder 15 mg lactosemonohydrat og bør ikke anvendes til patienter med arvelig galactoseintolerans, en særlig form for arvelig lactasemangel (Lapp lactase deficiency) eller glucose-galactose malabsorption.
English: • are a male and your female partner is of childbearing age (see section “Pregnancy and breast feeding”)
Danish: Tal med din læge, hvis du eller det barn, du er værge for: er kvinde i den fødedygtige alder (se afsnittet "Graviditet og amning"), er mand, og din kvindelige partner er i den fødedygtige alder (se afsnittet "Graviditet og amning"), tidligere har haft en hjertelidelse eller har en hjertesygdom,
English: Adverse Reactions
Danish: Overordnet respons
English: Pruritus, photosensitivity reaction, maculopapular rash, eczema, hyperhidrosis, acne, skin disorder, nail disorder, skin discolouration, dry skin, erythema, bruise
Danish: Pruritus, lysoverfølsomhedsreaktion, maculopapuløst udslæt, eksem, hyperhidrosis, akne, hudlidelse, neglelidelse, hudmisfarvning, tør hud, erythem, blå mærker
English: In a separate trial, 224 patients with genotype 2 or 3 received peginterferon alfa-2b, 1.5 microgram/kg subcutaneously, once weekly, in combination with ribavirin 800 mg-1,400 mg p.o. for 6 months
Danish: I en separat undersøgelse fik 224 patienter med genotype 2 eller 3 peginterferon alfa-2b, 1,5 mikrogram/kg subkutant en gang ugentligt i kombination med ribavirin 800 mg -1.400 mg p.o. i 6 måneder (baseret på legemsvægt, kun tre patienter, der vejede > 105 kg, fik 1.400 mg dosen) (Tabel 8).
English: How to take Ribavirin Mylan
Danish: Sådan skal du tage Ribavirin Mylan
English: MINIMUM PARTICULARS TO APPEAR ON UNIT DOSE BLISTERS
Danish: MINDSTEKRAV TIL MÆRKNING PÅ ENKELTDOSISBLISTER
English: Skin laceration
Danish: Tandkødsbetændelse
English: Chest pain, oedema, pain, feeling cold
Danish: Brystsmerter, ødem, kold følelse
English: This medicine in combination with an alpha interferon product may also cause: aplastic anaemia, pure red cell aplasia (a condition where the body stopped or reduced the production of red blood cells); this causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy, delusions, upper and lower respiratory tract infection, inflammation of the pancreas, severe rashes which may be associated with blisters in the mouth, nose, eyes and other mucosal membranes (erythema multiforme, Stevens Johnson syndrome), toxic epidermal necrolysis (blistering and peeling of the top layer of skin).
Danish: Dette forårsager svær anæmi, og symptomer herpå omfatter usædvanlig træthed og mangel på energi, - vrangforestilling, - øvre- og nedreluftvejsinfektion, - betændelse i bugspytkirtlen, - kraftigt udslæt, som kan optræde i forbindelse med blærer i mund, næse, øjne og andre slimhindemembraner (erythem muliforme, Stevens Johnson syndrom), toksisk epidermal nekrolyse (blæredannelse og afskalning af det øverste lag af huden).
English: The recommended dose and duration of ribavirin depends on patient's weight and on the medicinal product that is used in combination.
Danish: Den anbefalede dosis og varighed for ribavirin afhænger af patientens vægt og det lægemiddel, det bruges i kombination med. Se det tilsvarende produktresume for lægemidler, der anvendes i kombination med ribavirin.
English: Daily Ribavirin dose
Danish: Daglig ribavirin-dose